Imidazole → 6,7Dichloro-2,3-dimethoxy-5-(1-imidazol-1-ylethyl)quinoxaline
Reaction equation
Cl[CH:2]([C:4]1[C:13]([Cl:14])=[C:12]([Cl:15])[CH:11]=[C:10]2[C:5]=1[N:6]=[C:7]([O:18][CH3:19])[C:8]([O:16][CH3:17])=[N:9]2)[CH3:3].[NH:20]1[CH:24]=[CH:23][N:22]=[CH:21]1.C(=O)([O-])[O-].[K+].[K+]>CN(C)C=O>[Cl:14][C:13]1[C:4]([CH:2]([N:20]2[CH:24]=[CH:23][N:22]=[CH:21]2)[CH3:3])=[C:5]2[C:10](=[CH:11][C:12]=1[Cl:15])[N:9]=[C:8]([O:16][CH3:17])[C:7]([O:18][CH3:19])=[N:6]2Participants
5
Conditions
- Temperature
- 100 °C
Procedure
A mixture of 5-(1-chloroethyl)-6,7dichloro-2,3-dimethoxyquinoxaline (95 mg, 0.295 mmol), imidazole (22 mg, 0.325 mmol), anhydrous potassium carbonate (45 mg, 0.325 mmol) in dry dimethylformamide (10 mL) was heated under nitrogen at 100° C. for 6 hours, cooled, and partitioned between brine and three portions of ethyl acetate. The combined organic solutions were dried (MgSO4) and concentrated under reduced pressure. The residue was purified by flash column chromatography (gradient elution with dichloromethane:mehanol) to give 6,7dichloro-2,3-dimethoxy-5-(1-imidazol-1-ylethyl)quinoxaline (60 mg, 58%); as a yellow solid.
Workup
- temperaturecooled
- custompartitioned between brine and three portions of ethyl acetate
- dry with materialThe combined organic solutions were dried (MgSO4)
- concentrationconcentrated under reduced pressure
- customThe residue was purified by flash column chromatography (gradient elution with dichloromethane:mehanol)
Sources & evidence
- ORD record
- ord-3192c6fc49e14bf090c3436935f87c28
- Source dataset
- uspto-grants-1998_07
- Patent number
- US05783572
Reaction notes
Loading…